Citations 1
Phase IIIb study of the bevacizumab biosimilar candidate BI 695502 plus mFOLFOX6 in metastatic colorectal cancer
Bekaii‐Saab, Tanios , Balser, Sigrid , Lohmann, Ragna, Daoud, Hasan, Liedert, Bernd, Schliephake, Dorothee E., Bekaii-Saab, Tanios S
Colorectal Cancer | November 9, 2022 | Volume: 11 | Issue: 1 | Pages: No page available
